Effect of peripheral arterial disease on the onset of lactate threshold during cardiopulmonary exercise test: study protocol.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 27993904.
- Also identified by DOI 10.1136/bmjopen-2016-012763 and PMC identifier 5168619.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cardiopulmonary exercise test (CPET) is widely used in preoperative assessment and cardiopulmonary rehabilitation. The effect of peripheral arterial disease (PAD) on oxygen delivery (VO<sub>2</sub>) measured by CPET is not known. The aim of this study was to investigate the effect of PAD on VO<sub>2</sub> measurements during CPET. We designed a prospective cohort study, which will recruit 30 patients with PAD, who will undergo CPET before and after treatment of iliofemoral occlusive arterial disease. The main outcome measure is the difference in VO<sub>2</sub> at the lactate threshold (LT) between the 2 CPETs. The secondary outcome measure is the relationship between change in VO<sub>2</sub> at the LT and peak exercise pretreatment and post-treatment and haemodynamic measures of PAD improvement (ankle-brachial index differential). For VO<sub>2</sub> changes, only simple paired bivariate comparisons, not multivariate analyses, are planned, due to the small sample size. The correlation between ABI and VO<sub>2</sub> rise will be tested by linear regression. The study was approved by the North West-Lancaster Research and Ethics committee (reference 15/NW/0801). Results will be disseminated through scientific journal and scientific conference presentation. Completion of recruitment is expected by the end of 2016, and submission for publication by March 2017. NCT02657278.
Medical subject headings
- Anaerobic Threshold
- Exercise Test
- Lactic Acid
- Peripheral Arterial Disease
- Resistance Training